Glenmede Trust CO Na Astellas Pharma Inc Unsponsore Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$14.59 - $18.42 $4.4 Million - $5.55 Million	-301,253 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$13.79 - $17.44 $43,700 - $55,267	-3,169 Reduced 1.04%	301,253 $5.18 Million
Q3 2019 Nov 14, 2019	SELL	$13.91 - $14.42 $9,361 - $9,704	-673 Reduced 0.22%	304,422 $4.33 Million
Q2 2019 Aug 13, 2019	SELL	N/A	-1,188 Reduced 0.39%	305,095 $4.35 Million
Q1 2019 May 14, 2019	SELL	N/A	-244,027 Reduced 44.34%	306,283 $4.59 Million
Q4 2018 Feb 14, 2019	BUY	N/A	1,288 Added 0.23%	550,310 $7.03 Million
Q3 2018 Nov 15, 2018	BUY	N/A	1,517 Added 0.28%	549,022 $9.58 Million
Q2 2018 Aug 15, 2018	BUY	N/A	595 Added 0.11%	547,505 $8.35 Million
Q4 2017 Feb 15, 2018	BUY	N/A	542,773 Added 13119.97%	546,910 $6.97 Million
Q3 2017 Nov 14, 2017	BUY	N/A	4,137	4,137 $0

Others Institutions Holding ALPMY

# of Institutions

5

Shares Held

208K

Call Options Held

0

Put Options Held

0

About Astellas Pharma Inc Unsponsore

Ticker ALPMY
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,827,069,952
Market Cap $18.8B

More about ALPMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.